Literature DB >> 25341629

Can preoperative scoring systems be applied to Asian hip fracture populations? Validation of the Nottingham Hip Fracture Score (NHFS) and identification of preoperative risk factors in hip fractures.

Chung Yuan Kau1, Ernest B K Kwek.   

Abstract

INTRODUCTION: Hip fractures in the elderly are a major cause of morbidity and mortality. Determining which patients will benefit from hip fracture surgery is crucial to reducing mortality and morbidity. Our objectives are: 1) to define the rate of index admission, 1-month and 1-year mortality in all hip fracture patients, and 2) to apply the Nottingham Hip Fracture Score (NHFS) to determine validity in an Asian population.
MATERIALS AND METHODS: This is a prospective cohort study of 212 patients with hip fractures above 60 years from September 2009 to April 2010 for 1-year. Sociodemographic, prefracture comorbidity and data on functional status was collected on admission, and at intervals after discharge. The main outcome measures were mortality on index admission, 1 month and 12 months after treatment.
RESULTS: In our study, the overall mortality at 1-month and 1-year after surgery was 7.3% and 14.6% respectively. Surgically treated hip fracture patients had lower odds ratio (OR) for mortality as compared to conservatively treated ones. The OR was 0.17 during index admission, 0.17 at 1-month, and 0.18 at 12-months after discharge. These were statistically significant. Adjustments for age, gender, and duration to surgery were taken into account. The NHFS was found to be a good predictor of 1-month mortality after surgery.
CONCLUSION: Surgically treated hip fracture patients have a lower OR for mortality than conservatively managed ones even up to 1-year. The NHFS has shown to predict 1-month mortality accurately for surgically treated hip fracture patients, even for our Asian population. It can be used as a tool for clinicians at the individual patient level to communicate risk with patients and help plan care for fracture patients.

Entities:  

Mesh:

Year:  2014        PMID: 25341629

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  7 in total

1.  A new preoperative risk score for predicting mortality of elderly hip fracture patients: an external validation study.

Authors:  Zhicong Wang; Xi Chen; Ling Yang; Hong Wang; Wei Jiang; Yuehong Liu
Journal:  Aging Clin Exp Res       Date:  2021-01-24       Impact factor: 3.636

2. 

Authors:  Berrin Günaydın; Ömer Kurtipek
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-06-01

3.  Validation of the Nottingham Hip Fracture Score (NHFS) in Patients with Hip Fracture: A Prospective Cohort Study in the Netherlands.

Authors:  Veronique A J I M van Rijckevorsel; Gert R Roukema; Taco M A L Klem; Tjallingius M Kuijper; Louis de Jong
Journal:  Clin Interv Aging       Date:  2021-08-21       Impact factor: 4.458

4.  Relationship between comorbidities and treatment decision-making in elderly hip fracture patients.

Authors:  Jinxing Wei; Li Zeng; Shitong Li; Fang Luo; Zhou Xiang; Qunfang Ding
Journal:  Aging Clin Exp Res       Date:  2019-04-16       Impact factor: 3.636

5.  Evaluation of Nottingham Hip Fracture Score, Age-Adjusted Charlson Comorbidity Index and the Physiological and Operative Severity Score for the enumeration of Mortality and morbidity as predictors of mortality in elderly neck of femur fracture patients.

Authors:  Michael James Nelson; Justin Scott; Palvannan Sivalingam
Journal:  SAGE Open Med       Date:  2020-04-28

6.  Predictors of poor functional outcomes and mortality in patients with hip fracture: a systematic review.

Authors:  Bang Yu Xu; Shi Yan; Lian Leng Low; Farhad Fakhrudin Vasanwala; Sher Guan Low
Journal:  BMC Musculoskelet Disord       Date:  2019-11-27       Impact factor: 2.362

7.  Validity of Nottingham Hip Fracture Score in Different Health Systems and a New Modified Version Validated to the Greek Population.

Authors:  Konstantinos Tilkeridis; Athanasios Ververidis; Georgios Kiziridis; Dimitrios Kotzamitelos; Dimitrios Galiatsatos; Rodion Mavropoulos; Katerina Vlastimil Rechova; Georgios Drosos
Journal:  Med Sci Monit       Date:  2018-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.